Skip to main content
Fig. 2 | Renal Replacement Therapy

Fig. 2

From: Impact on change in serum beta 2 microglobulin by combination therapy of peritoneal dialysis and hemodialysis: a 12-month preliminary observational study

Fig. 2

Changes in serum β2 microglobulin by PD + HD combination therapy over 12 months. PD peritoneal dialysis, HD hemodialysis. Repeated-measures analysis of variance (ANOVA) with Tukey corrections revealed statistically significant decreases in serum β2 microglobulin over the 12-month follow-up (p = 0.006). Mean values of β2MG (mean ± standard deviation) at 0, 3, 6, and 12 months were 36.7 ± 6.7 mg/L, 33.4 ± 6.1 mg/L, 32.9 ± 4.5 mg/L and 33.3 ± 5.3 mg/L, respectively

Back to article page

Renal Replacement Therapy

ISSN: 2059-1381

Contact us